Cancian L, Hansen A, Boshoff C (2013) Cellular origin of Kaposi’s sarcoma and
Kaposi’s sarcoma- associated herpesvirus-induced cell reprogramming. Trends Cell Biol
23(9):421–432
Adams RH, Alitalo K (2007) Molecular regulation of angiogenesis and lymphangiogenesis.
Nat Rev Mol Cell Biol 8(6):464–478
Salahuddin SZ et al (1988) Angiogenic properties of Kaposi’s sarcoma-derived cells after
long-term culture in vitro. Science 242(4877):430–433
Ensoli B et al (1989) AIDS-Kaposi’s sarcoma-derived cells express cytokines with autocrine
and paracrine growth effects. Science 243(4888):223–226
Samaniego F et al (1995) Inflammatory cytokines induce AIDS-Kaposi’s sarcoma-derived
spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi’s
sarcoma-like lesion formation in nude mice. J Immunol 154(7):3582–3592
Samaniego F et al (1997) Inflammatory cytokines induce endothelial cells to produce and
release basic fibroblast growth factor and to promote Kaposi’s sarcoma-like lesions in nude
mice. J Immunol 158(4):1887–1894
Mansouri M et al (2008) Remodeling of endothelial adherens junctions by Kaposi’s sarcoma-
associated herpesvirus. J Virol 82(19):9615–9628
Qian LW et al (2008) Kaposi’s sarcoma-associated herpesvirus disrupts adherens junctions
and increases endothelial permeability by inducing degradation of VE-cadherin. J Virol
82(23):11902–11912
Wang L, Damania B (2008) Kaposi’s sarcoma-associated herpesvirus confers a survival
advantage to endothelial cells. Cancer Res 68(12):4640–4648
DiMaio TA, Gutierrez KD, Lagunoff M (2011) Latent KSHV infection of endothelial cells
induces integrin beta3 to activate angiogenic phenotypes. PLoS Pathog 7(12):e1002424
Gasperini P et al (2012) Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal
transition through notch-dependent signaling. Cancer Res 72(5):1157–1169
Qian LW et al (2007) Kaposi’s sarcoma-associated herpesvirus infection promotes invasion
of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases.
J Virol 81(13):7001–7010
Watanabe T et al (2003) Kaposi’s sarcoma-associated herpesvirus latency-associated nuclear
antigen prolongs the life span of primary human umbilical vein endothelial cells. J Virol
77(11):6188–6196
Murakami Y et al (2006) Ets-1-dependent expression of vascular endothelial growth factor
receptors is activated by latency-associated nuclear antigen of Kaposi’s sarcoma-associated
herpesvirus through interaction with Daxx. J Biol Chem 281(38):28113–28121
He M et al (2012) Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is
mediated by EZH2. Cancer Res 72(14):3582–3592
Wang X et al (2014) Latency-associated nuclear antigen of Kaposi sarcoma-associated her-
pesvirus promotes angiogenesis through targeting notch signaling effector Hey1. Cancer Res
74(7):2026–2037
Bais C et al (1998) G-protein-coupled receptor of Kaposi’s sarcoma-associated herpesvirus is
a viral oncogene and angiogenesis activator. Nature 391(6662):86–89
Sodhi A et al (2000) The Kaposi’s sarcoma-associated herpes virus G protein-coupled recep-
tor up-regulates vascular endothelial growth factor expression and secretion through mitogen-
activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer
Res 60(17):4873–4880
Aoki Y et al (1999) Angiogenesis and hematopoiesis induced by Kaposi’s sarcoma- associated
herpesvirus-encoded interleukin-6. Blood 93(12):4034–4043
Vart RJ et al (2007) Kaposi’s sarcoma-associated herpesvirus-encoded interleukin-6 and
G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells.
Cancer Res 67(9):4042–4051
Xie J et al (2005) Kaposi’s sarcoma-associated herpesvirus induction of AP-1 and interleukin
6 during primary infection mediated by multiple mitogen-activated protein kinase pathways.
J Virol 79(24):15027–15037
